1-4 of 4
Shigeki Saito
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prospective Study of the Usefulness of Liquid Biopsy in Patients with Unknown Fever Suspected of Malignant Lymphoma

Akinao Okamoto, Masashi Sanada, Takahiko Yasuda, Seiichi Kato, Akira Satou, Kosei Matsue, Hiroki Hosoi, Masahiro Yoshida, Satsuki Murakami, Eisei Kondo, Yasufumi Masaki, Yasuhiro Suzuki, Kana Miyazaki, Tomohiro Kajiguchi, Junji Hiraga, Shingo Kurahashi, Yuichiro Inagaki, Kazutaka Ozeki, Shigeki Saito, Toshiki Terao, Sachiko Iba, Keiko Hattori, Hideyuki Yamamoto, Naoe Goto, Chisako Iriyama, Masataka Okamoto, Akihiro Tomita
Journal: Blood
Blood (2022) 140 (Supplement 1): 6690–6692.
https://doi.org/10.1182/blood-2022-157438
Published: 2022
Journal Articles

Final Results From SENSOR: Switch to Nilotinib After Molecular Suboptimal Response (SoR) to Frontline Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

Mitsune Tanimoto, MD PhD, Koichi Miyamura, Toshihiro Miyamoto, MD PhD, Kazuhito Yamamoto, Masafumi Taniwaki, Shinya Kimura, MD, Kazuma Ohyashiki, Tatsuya Kawaguchi, MD PhD, Itaru Matsumura, Tomoko Hata, MD PhD, Hisashi Tsurumi, MD PhD, Shigeki Saito, MD PhD, Masayuki Hino, MD PhD, Seiji Tadokoro, Kuniaki Meguro, MD PhD, Hideo Hyodo, MD, Masahide Yamamoto, MD PhD, Kohmei Kubo, MD PhD, Junichi Tsukada, MD, Midori Kondo, Makoto Aoki, Hikaru Okada, Masamitsu Yanada
Journal: Blood
Blood (2014) 124 (21): 1815.
https://doi.org/10.1182/blood.V124.21.1815.1815
Published: 2014
Journal Articles

Nilotinib Following Molecular Suboptimal Response (SoR) To Imatinib In Japanese Patients (pts) With Chronic Myeloid Leukemia In Chronic Phase (CML-CP): 12 Month Follow-Up From The SENSOR Study

Koichi Miyamura, MD, PhD, Toshihiro Miyamoto, MD, Mineo Kurokawa, MD, PhD, Mitsune Tanimoto, MD, PhD, Kazuhito Yamamoto, M.D., Ph.D., Masafumi Taniwaki, MD, PhD, Shinya Kimura, MD, PhD, Kazuma Ohyashiki, MD, PhD, Tatsuya Kawaguchi, MD, PhD, Itaru Matsumura, MD, PhD, Tomoko Hata, MD, PhD, Hisashi Tsurumi, MD, PhD, Shigeki Saito, MD, PhD, Masayuki Hino, MD, PhD, Seiji Tadokoro, Kuniaki Meguro, M.D., Ph.D., Hideo Hyodo, MD, Masahide Yamamoto, MD, Kohmei Kubo, MD, Junichi Tsukada, Midori Kondo, Taro Amagasaki, PhD, Eiji Kawahara, PhD, Masamitsu Yanada
Journal: Blood
Blood (2013) 122 (21): 2729.
https://doi.org/10.1182/blood.V122.21.2729.2729
Published: 2013
Journal Articles

Mast Cells As a Therapeutic Target for Hodgkin Lymphoma: Bortezomib Inhibits Mast Cell-Induced Modification of the Tumor Microenvironment

Hiroki Mizuno, MD, Takayuki Nakayama, MD, PhD, Yasuhiko Miyata, MD, PhD, Shigeki Saito, MD, PhD, Nishiwaki Satoshi, MD, PhD, Norihiko Nakao, Kyosuke Takeshita, Akihiro Tomita, MD, Ph.D., Tomoki Naoe, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 3634.
https://doi.org/10.1182/blood.V120.21.3634.3634
Published: 2012